Project NextGen

Attachments

*Funding: Biodefense, Toxic Exposure, Poison, Disaster Response, Recover & Relief, Disease & Post Market Surveillance, Biosurveillance, Public Health Emergency (PHE), Environmental Health, Water Purification / Safety, All Hazards, PPE & CBRNE (Chemical, Biological, Radiological, Nuclear, Explosives), WMD (Weapons of Mass Destruction) & Refugee Support
*Funding: BioPharmaceuticals _ Vaccines, Vaccination & Immunization
*Funding: Diagnostics
*Funding: Emergency Medicine, Combat Casualty Care, Trauma, Blast, First Responder, Autonomous Care & Operational Medicine (OpMed)
*Funding: HHS_ASPR (Administration for Strategic Preparedness and Response)
*Funding: HHS_BARDA
*Funding: Infectious Disease _ Influenza (Avian Flu, H1N1, H5N1, H5N2)
*Funding: Infectious Disease_Bacteria, Antibiotics_Bacteriology
*Funding: Infectious Disease_Virus, Antiviral, Antivirus, Virology
*Funding: Pandemic, Outbreak & Epidemic Resiliency_[Coronavirus, Covid-19, SARS-CoV-2, H5N1 Avian Influenza,Mpox]
*Funding: Wound, Burn Care and Infection Control
Organization & Developments: ASPR

*Project NextGen, is a $5 billion initiative led by ASPR’s Biomedical Advanced Research and Development Authority (BARDA) in partnership with the National Institute of Allergy and Infectious Diseases (NIAID), coordinates across the federal government and the private sector to advance innovative vaccines and therapeutics into clinical trials, regulatory review, and potential commercial availability for the American people. The project builds on a better understanding of COVID-19 – with HHS developing, using, and constantly re-evaluating the strengths and weaknesses of current vaccines and therapeutics for over three years.
2023: First on CNN: HHS awards more than $500 million to study Covid-19 vaccine nasal sprays and more
2027: BARDA DRIVe EZ-BAA (EZBAA - 22-100-SOL-00003)_SAM.gov
2028: BARDA Broad Agency Announcement (BAA)_Medical Countermeasures
BioNTech SE (NASDAQ: BNTX)*
CastleVax Inc.
Codagenix
Gritstone bio, Inc. (NASDAQ: GRTS), former, Gritstone Oncology*
Luminary Labs
Moderna, Inc. (NASDAQ:MRNA)*
Novavax, Inc. (Nasdaq:NVAX)*
Pfizer Inc. (NYSE: PFE)